20 May 2013
Keywords: Regeneron, Sanofi, SAR236553, REGN727, Ph II, Cholesterol lowerer
Article | 27 May 2012
USA-based Regeneron (Nasdaq: REGN) and French drug major Sanofi (Euronext: SAN) presented results of their third and final Phase II ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
27 May 2012
28 May 2012
© 2013 thepharmaletter.com